Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking a week's break from Mounjaro is possible, but it comes with real consequences worth understanding before you decide. Tirzepatide stays active in your body for roughly a week after a missed dose, so a single skipped injection is not the clinical cliff-edge it might feel like — but a planned seven-day pause is a different matter. These are prescription-only medicines, and any decision to interrupt treatment should involve your prescriber rather than a quiet judgment call. Here is what the evidence and clinical guidance actually say.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Before weighing up whether to pause, it helps to know what a missed week actually means pharmacologically. Tirzepatide's elimination half-life is approximately five days. That means roughly half the drug from your last injection is still circulating a week later. You will not wake up on day eight with zero tirzepatide in your system. The appetite-quieting effect fades progressively rather than vanishing at once.
In practice, most people notice hunger returning somewhere between day five and day ten after their last injection. Portion sizes that felt comfortable during treatment start to feel insufficient. That is not a sign of failure, it is the drug doing less of what it was doing. The NHS patient information on tirzepatide notes that it works by activating receptors involved in appetite regulation and slowing gastric emptying, so as levels drop, those effects unwind too.
If you want a quick way to gauge where you are, pay attention to how long after your usual injection day hunger noticeably picks up. Many people find that tracking this (even just a mental note) gives them a practical sense of their personal response curve. One week off means you will almost certainly be in the window where hunger has returned meaningfully before your next scheduled dose would have been due.
There are situations where a temporary pause is genuinely unavoidable rather than optional. Surgery is the clearest example: NHS England advises informing your anaesthetist and surgical team that you take tirzepatide before any procedure, and some surgical teams request a pause because of the effect on gastric emptying and aspiration risk. This is a clinical decision, made with the people responsible for your care, not something to arrange unilaterally.
Other situations (a prolonged illness that makes injecting impractical, a supply interruption, travel to a location where the pen cannot be stored correctly) may also create a gap. If you are wondering about the broader question of when stopping Mounjaro is the right call rather than pausing it, that is a separate and more considered decision.
What none of these situations have in common is a therapeutic reason to take a week off simply to see what happens or to give your body a rest. There is no evidence that planned breaks improve outcomes, and some evidence from weight-management research that interrupting effective treatment creates unnecessary volatility in appetite and weight.
Coming back on after a one-week pause is not the same as resuming after a month or more. If you missed a single injection and the gap is under fourteen days, standard clinical guidance allows resuming at your current dose at the next scheduled time. Beyond fourteen days, the picture shifts and your prescriber may recommend stepping back to a lower dose to reduce the risk of gastrointestinal side effects, which are most noticeable when drug levels rise sharply after a period of absence.
The detailed thinking behind how to come off Mounjaro safely covers this ground, but the short version is: the longer the gap, the more careful the restart. A week sits at the more forgiving end of that spectrum, but your prescriber's view takes precedence over any general guide.
One thing worth knowing: the side-effect profile on restarting after a break can mimic the early weeks of treatment. Nausea and digestive discomfort that had settled may briefly return. Staying well-hydrated, eating smaller amounts until your system readjusts, and not treating the restart as a chance to eat freely beforehand all help. If you are thinking about managing weight during and after any break, there is practical guidance on what actually makes a difference.
A planned week off Mounjaro is the kind of decision that sounds simple but has more moving parts than it appears. Your dose, how long you have been on treatment, any other medicines you take, and the reason for the pause all affect what the right approach looks like. The NHS England guidance on weight-management injections is clear that these medicines work best as part of consistent, clinically supported treatment, not as something to dip in and out of.
If you are considering a pause because you are thinking about stopping altogether, questions about whether you can simply stop or how to come off tirzepatide more formally are worth exploring first. A week off is not the same as stopping, but it can be the start of an unplanned longer gap if hunger returns strongly and confidence dips.
At nume, every repeat order is reviewed by a GPhC-registered prescriber before it is dispensed, a real clinician reads your notes, not software. If you have a situation that affects your dosing schedule, that is exactly the kind of thing to raise through our support team or at your next review. If you are not yet on treatment and are working out whether Mounjaro is right for you, our Mounjaro information page covers eligibility and how the medicine works in full. When you are ready to take the next step, you can start your free consultation and have your answers reviewed the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.